Acute Erythroid Leukemia: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
|||
| Line 54: | Line 54: | ||
! Finding !! Marker | ! Finding !! Marker | ||
|- | |- | ||
|Positive (universal) || | |Positive (universal) || Hemoglobin A, Glycophorin A, Spectrin, ABH blood group antigens, and HLA-DR | ||
|- | |- | ||
|Positive (subset) || | |Positive (subset) || CD13, CD33, CD34, CD117 (KIT), and MPO, Gerbich blood group (Gero) antibody, carbonic anhydrase 1, and CD36, CD41 and CD61 | ||
|- | |- | ||
|Negative (universal) || | |Negative (universal) || Myeloid-associated markers such as MPO,CD13,CD33,CD61, B and T Cell markers -CD10, CD19, CD79a, CD2, CD3, CD5, monocytic markers CD11c CD14 | ||
Megakaryoblastic markers: CD61, Others: CD34, anti-kappa, anti-lambda, CD45 | |||
|- | |- | ||
|Negative (subset) || | |Negative (subset) || HLA-DR, CD34, Glycophorin A | ||
|} | |} | ||